[HTML][HTML] Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients

M Peghin, M De Martino, A Palese, V Gerussi… - Clinical Microbiology …, 2022 - Elsevier
Objectives This study aimed to describe the impact of vaccination and the role of humoral
responses on post–COVID-19 syndrome 1 year after the onset of SARS coronavirus type 2 …

[HTML][HTML] Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients

M Peghin, A Palese, M Venturini, M De Martino… - Clinical Microbiology …, 2021 - Elsevier
Objectives To assess the prevalence of and factors associated with post-coronavirus
disease 2019 (COVID-19) syndrome 6 months after the onset. Methods A bidirectional …

Seroprevalence and levels of IgG antibodies after COVID-19 infection or vaccination

H Soeorg, P Jõgi, P Naaber, A Ottas… - Infectious …, 2022 - Taylor & Francis
Background In a country-wide seroprevalence study of COVID-19 in Estonia, we aimed to
determine the seroprevalence and the dynamics of IgG against SARS-CoV-2 after …

SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study

WA Mak, JGM Koeleman, M van der Vliet, F Keuren… - Journal of Infection, 2022 - Elsevier
Objectives First, to describe SARS-CoV-2 T cell and antibody responses in a prospective
cohort of healthcare workers that suffered from mild to moderate COVID-19 approximately …

Antibodies responses to SARS-CoV-2 in a large cohort of vaccinated subjects and seropositive patients

E Amodio, G Capra, A Casuccio, SD Grazia… - Vaccines, 2021 - mdpi.com
COVID-19 is a current global threat, and the characterization of antibody response is vitally
important to update vaccine development and strategies. In this study we assessed SARS …

[HTML][HTML] Vaccination after developing long COVID: Impact on clinical presentation, viral persistence, and immune responses

M Nayyerabadi, L Fourcade, SA Joshi… - International Journal of …, 2023 - Elsevier
Background Vaccination protects against severe COVID-19 manifestations. For those with
post-COVID-19 conditions (PCC) or long COVID, the impact of COVID-19 vaccination on the …

Anti-SARS-CoV-2 antibody levels and kinetics of vaccine response: potential role for unresolved inflammation following recovery from SARS-CoV-2 infection

F Gianfagna, G Veronesi, A Baj, D Dalla Gasperina… - Scientific reports, 2022 - nature.com
The immune response after SARS-CoV-2 vaccine administration appears to be
characterized by high inter-individual variation, even in SARS-CoV-2 positive subjects, who …

[HTML][HTML] Antibody response to SARS-CoV-2 is associated with long-term clinical outcome in patients with COVID-19: a longitudinal study

J García-Abellán, S Padilla… - Journal of clinical …, 2021 - Springer
Background The relationship of host immune response and viral replication with health
outcomes in patients with COVID-19 remains to be defined. We aimed to characterize the …

Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel

V Glück, S Grobecker, J Köstler, L Tydykov, M Bertok… - Infection, 2021 - Springer
Background The long-term course of immunity among individuals with a history of COVID-
19, in particular among those who received a booster vaccination, has not been well defined …

Long-term kinetics of SARS-CoV-2 antibodies and impact of inactivated vaccine on SARS-CoV-2 antibodies based on a COVID-19 patients cohort

S Zhang, K Xu, C Li, L Zhou, X Kong, J Peng… - Frontiers in …, 2022 - frontiersin.org
Background Understanding the long-term kinetic characteristics of SARS-CoV-2 antibodies
and the impact of inactivated vaccines on SARS-CoV-2 antibodies in convalescent patients …